drugset / Trial / NCT06138210
The Effect of GD-iExo-003 in Acute Ischemic Stroke
RandomizedSequentialQuadruple-blindTreatment
Summary
This is a multicenter, randomized, double-blinded, placebo-controlled, dose-escalation trial. The objective of this study is evaluating safety and preliminary efficacy of intravenous exosomes derived from human induced pluripotent stem cell (GD-iExo-003) in acute ischemic stroke.
Timeline
- Start
- 2024-06-05
- Primary completion
- 2026-03-30
- Completion
- 2026-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GD-iExo-003 | Other / unclassified | 2e+09 unknown | Intravenous |
| Subject | GD-iExo-003 | Other / unclassified | 4e+09 unknown | Intravenous |
| Subject | GD-iExo-003 | Other / unclassified | 8e+09 unknown | Intravenous |